In Section C, members will get ABBV-744 and oral navitoclax. In Section D, members will get ABBV-744 and ruxolitinib. Members will obtain treatment until finally sickness progression or maybe the contributors are unable to tolerate the study drugs. Possible new ways with the diagnosis and treatment of AML. (A) The https://clinicaleffectivenessofab79023.blog-mall.com/32509414/5-easy-facts-about-abbv-744-combination-therapy-with-chemotherapy-described